Tag: AS
Positive top-line results for second phase 3 study of Taltz in...
The results of the COAST-W trial demonstrate that Taltz (ixekizumab; Eli Lilly and Company) is a safe and effective treatment for Ankylosing Spondylitis (AS),...
CIMZIA effective in treating axial spondyloarthritis patients
CIMZIA (certolizumab pegol) is the first therapy to demonstrate positive results in a 52-week, placebo controlled non-radiographic axial spondyloarthritis study. The positive topline results...